Literature DB >> 2760457

Effect of endogenous vasoconstrictors on maternal intramyometrial and fetal stem villous arteries in pre-eclampsia.

J Allen1, A Forman, S Maigaard, L T Jespersen, K E Andersson.   

Abstract

The contractile responses to various endogenous vasoactive agents were investigated in isolated human uteroplacental arteries from normotensive (NT) patients and patients with pre-eclampsia (PE) undergoing caesarian section. Tissue samples were obtained from the uterine incision and from macroscopically normal cotyledons. Vascular ring preparations of intramyometrial and stem villous arteries (length 1.0-1.3 mm, outer diameter 400-600 microns) were dissected and mounted in organ baths and isometric tension was recorded. Concentration-response relationships for vasopressin (VP), oxytocin (OX), angiotensin II (Ang II), noradrenaline (NA), 5-hydroxytryptamine (5-HT), prostaglandin F2 alpha (PGF2 alpha) and prostaglandin E2 (PGE2) were assessed. For each compound, the mean maximum contractile effect (Emax) and the drug concentration producing half-maximal response (EC50) were determined. In intramyometrial arteries from NT and PE patients, VP, Ang II, NA, 5-HT and PGF2 alpha induced contraction while OX and PGE2 produced weak or no responses. Preparations from PE patients showed higher Emax values, while no differences in EC50 were found between the two groups. In fetal stem villous arteries, Ang II, 5-HT, PGF2 alpha and PGE2 induced contractions, while VP, NA and OX produced weak responses. No differences in Emax or EC50 values were found between the fetal vessels of PE and NT patients. No qualitative differences were demonstrated in response to the agents tested between the vessels (fetal and maternal) from NT women at term and PE patients. However, the results may reflect quantitative differences, suggesting increased contractility of maternal uteroplacental arteries from women with PE.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760457     DOI: 10.1097/00004872-198907000-00004

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

Review 1.  Noninvasive 24 hour ambulatory blood pressure monitoring: current status.

Authors:  A Stanton; E O'Brien
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

Review 2.  Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders.

Authors:  Thomas Walther; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

3.  DNA methylation-reprogrammed oxytocin receptor underlies insensitivity to oxytocin in pre-eclamptic placental vasculature.

Authors:  Xiaorong Fan; Ting Xu; Hongmei Ding; Huan Li; Yuxian Yang; Yun He; Jiaqi Tang; Yanping Liu; Xueyi Chen; Jie Chen; Jianying Tao; Zhice Xu; Qinqin Gao
Journal:  J Cell Mol Med       Date:  2019-04-04       Impact factor: 5.310

Review 4.  Research progress of placental vascular pathophysiological changes in pregnancy-induced hypertension and gestational diabetes mellitus.

Authors:  Jiahui Lei; Meng Zhao; Lingjun Li; Bingyu Ji; Ting Xu; Miao Sun; Jie Chen; Junlan Qiu; Qinqin Gao
Journal:  Front Physiol       Date:  2022-07-19       Impact factor: 4.755

5.  A novel mechanism of angiotensin II-regulated placental vascular tone in the development of hypertension in preeclampsia.

Authors:  Qinqin Gao; Jiaqi Tang; Na Li; Xiuwen Zhou; Yongmei Li; Yanping Liu; Jue Wu; Yuxian Yang; Ruixiu Shi; Axin He; Xiang Li; Yingying Zhang; Jie Chen; Lubo Zhang; Miao Sun; Zhice Xu
Journal:  Oncotarget       Date:  2017-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.